← Back to Search

Unique measurement (AutoSTRAIN) by a commercial software program (TOMTEC-ARENA) for Atrial Fibrillation

N/A
Waitlist Available
Research Sponsored by Crystal Blake-Parlin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is investigating whether left atrial global longitudinal strain is a predictive measure of maintaining normal sinus rhythm post cardioversion in patients with atrial fibrillation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Patients With a Relationship Between Left Atrial Global Longitudinal Strain and the Maintenance of Sinus Rhythm After Cardioversion

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients identified at PBMC with a documented diagnosis of AFExperimental Treatment1 Intervention
Patients identified at PBMC with a documented diagnosis of AF (at any point in time) and who have undergone any cardioversion.

Find a Location

Who is running the clinical trial?

Crystal Blake-ParlinLead Sponsor
MaineHealthOTHER
71 Previous Clinical Trials
49,098 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
444 Patients Enrolled for Atrial Fibrillation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of participant recruitment for this investigation?

"Affirmative. According to the information captured on clinicaltrials.gov, this health-related research is currently searching for patients and was initially posted on May 1st 2020. The trial is aiming to recruit 150 individuals from one facility by September 16th 2021."

Answered by AI

Is enrollment still open for participants in this trial?

"Affirmative. According to clinicaltrials.gov, the experiment initially posted on May 1st 2020 is still actively recruiting participants. The most recent update was made on September 16th 2021 and 150 people are sought from one single site."

Answered by AI
~43 spots leftby Apr 2025